0

NAMI-A

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP201653761
CAS201653-76-1
Molecular Weight458.18
Description≥98% ruthenium (Ru) basis (elemental analysis)
SolubilityH2O: 2 mg/mL, clear
Assay≥98% ruthenium (Ru) basis (elemental analysis)
Colorfaint red to dark brown
Formpowder
Size10MG, 50MG
Storage Conditions−20°C
1

Comparison of KP1019 and NAMI-A in Tumour-Mimetic Environments

Gemma K Gransbury, Peter Kappen, Chris J Glover, James N Hughes, Aviva Levina, Peter A Lay, Ian F Musgrave, Hugh H Harris

Metallomics. 2016 Aug 1;8(8):762-73.

PMID: 27460862

1

Effects of the Ruthenium-Based Drug NAMI-A on the Roles Played by TGF-β1 in the Metastatic Process

L Brescacin, A Masi, G Sava, A Bergamo

J Biol Inorg Chem. 2015 Oct;20(7):1163-73.

PMID: 26369538

1

Influence of the Binding of Reduced NAMI-A to Human Serum Albumin on the Pharmacokinetics and Biological Activity

V Novohradský, A Bergamo, M Cocchietto, J Zajac, V Brabec, G Mestroni, G Sava

Dalton Trans. 2015 Jan 28;44(4):1905-13.

PMID: 25489765

1

NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry

Enzo Alessio, Luigi Messori

Molecules. 2019 May 24;24(10):1995.

PMID: 31137659

1

The NAMI A - Human Ferritin System: A Biophysical Characterization

Silvia Ciambellotti, Alessandro Pratesi, Mirko Severi, Giarita Ferraro, Enzo Alessio, Antonello Merlino, Luigi Messori

Dalton Trans. 2018 Aug 21;47(33):11429-11437.

PMID: 30063237

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode